Tuberculosis (TB) remains the leading infectious cause of mortality in the world today. Both treatment and control of this deadly disease are increasingly hampered by the emergence of multidrug resistant (MDR) strains of M. tuberculosis. While poor compliance and/or inadequate TB therapy clearly provides the selection pressure driving the evolution of drug resistant strains, the process is complex, likely involving both host and mycobacterial determinants as well. We hypothesize that interactions between selected mycobacterial properties that interfere with the induction of the host immune response or resist the effects of this response can act to increase bacillary growth and survival and thus the propensity of acquiring drug resistance. The consequence of this occurring over time will be an enrichment of specific strains among the drug resistant cases within communities where TB is endemic. Our overall goal in these studies is to define determinants in M. tuberculosis that can contribute to develop drug resistance in human populations. We propose to 1) Carry out a carefully designed case-control study to characterize the natural distribution of MDR-TB and non-MDR-TB M. tuberculosis strains circulating in a defined human population with high endemic TB; 2) Test the hypothesis that an M. tuberculosis phenol glycolipid (PGL-tb), which induces a host immune response that fails to control bacillary growth efficiently, is therefore associated with an increased resistance in the host; and 3) Examine the interaction between host oxidative stress and DNA repair mechanisms in the acquisition of drug resistance in M. tuberculosis. Because a multidisciplinary approach is required to achieve these objectives, we have assembled a team of collaborators with a range of expertise to enable us to tease apart the many facets of this complex infectious disease problem. ? ? Multidrug-resistant tuberculosis (MDR TB) is associated with high morbidity and mortality, prolonged treatment to cure, and increased risk of spread in the community. We will test the hypothesis that some naturally occurring strains of M. tuberculosis are more prone to develop drug resistance than others. Results of these studies can contribute to improved TB control strategies aimed at reducing the emergence of MDR- TB and the development of new therapeutic approaches for combating this deadly disease. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI066046-04
Application #
7476444
Study Section
Host Interactions with Bacterial Pathogens Study Section (HIBP)
Program Officer
Sizemore, Christine F
Project Start
2006-08-15
Project End
2010-07-31
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
4
Fiscal Year
2008
Total Cost
$323,659
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
623946217
City
Newark
State
NJ
Country
United States
Zip Code
07107
Middelkoop, Keren; Mathema, Barun; Myer, Landon et al. (2015) Transmission of tuberculosis in a South African community with a high prevalence of HIV infection. J Infect Dis 211:53-61
Middelkoop, Keren; Bekker, Linda-Gail; Mathema, Barun et al. (2014) Factors affecting tuberculosis strain success over 10 years in a high TB- and HIV-burdened community. Int J Epidemiol 43:1114-22
Middelkoop, K; Bekker, L-G; Shashkina, E et al. (2012) Retreatment tuberculosis in a South African community: the role of re-infection, HIV and antiretroviral treatment. Int J Tuberc Lung Dis 16:1510-6
Mathema, Barun; Kurepina, Natalia; Yang, Guibin et al. (2012) Epidemiologic consequences of microvariation in Mycobacterium tuberculosis. J Infect Dis 205:964-74
Sinsimer, Daniel; Fallows, Dorothy; Peixoto, Blas et al. (2010) Mycobacterium leprae actively modulates the cytokine response in naive human monocytes. Infect Immun 78:293-300
Middelkoop, Keren; Bekker, Linda-Gail; Mathema, Barun et al. (2009) Molecular epidemiology of Mycobacterium tuberculosis in a South African community with high HIV prevalence. J Infect Dis 200:1207-11
Churchyard, Gavin J; Kaplan, Gilla; Fallows, Dorothy et al. (2009) Advances in immunotherapy for tuberculosis treatment. Clin Chest Med 30:769-82, ix
Soares, Andreia P; Scriba, Thomas J; Joseph, Sarah et al. (2008) Bacillus Calmette-Guerin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J Immunol 180:3569-77
El Kasmi, Karim C; Qualls, Joseph E; Pesce, John T et al. (2008) Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat Immunol 9:1399-406
Sinsimer, Daniel; Huet, Gaelle; Manca, Claudia et al. (2008) The phenolic glycolipid of Mycobacterium tuberculosis differentially modulates the early host cytokine response but does not in itself confer hypervirulence. Infect Immun 76:3027-36